Gene Expression Profiling of Liver Metastases from Colorectal Cancer
Author Information
Author(s): Pantaleo M A, Astolfi A, Nannini M, Paterini P, Piazzi G, Ercolani G, Brandi G, Martinelli G, Pession A, Pinna A D, Biasco G
Primary Institution: University of Bologna
Hypothesis
The study aims to identify molecular patterns in gene expression of synchronous and metachronous liver metastases to inform treatment choices.
Conclusion
Synchronous and metachronous liver metastases from colorectal cancer exhibit different gene expression signatures, which may guide treatment decisions.
Supporting Evidence
- The study identified 49 genes upregulated in metachronous and 55 genes in synchronous metastases.
- EGFr was overexpressed in metachronous lesions, while COX-2 was overexpressed in synchronous lesions.
- Differential expression of genes was confirmed through quantitative PCR and protein analysis.
Takeaway
Doctors can use the differences in gene expression between two types of liver cancer spread to choose better treatments for patients.
Methodology
The study used Affymetrix microarrays to analyze gene expression in liver metastases from 18 patients, comparing synchronous and metachronous lesions.
Limitations
The findings need to be confirmed in larger studies.
Participant Demographics
{"total_patients":18,"male":10,"female":8,"age_median":63,"age_range":"41-77"}
Statistical Information
P-Value
{"EGFr":0.046,"COX-2":0.012}
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website